Alteration of the systemic and microcirculation by a single oral dose of flavan-3-ols

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Ingawa, Kodai ^a   Aruga, Nozomi ^a   Matsumura, Yusuke ^a   Shibata, Masahiro ^a   Osakabe, Naomi ^a  

^a SHIBAURA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVAN 3 OL; FLAVAN DERIVATIVE; NITRATE; NITRITE; UNCLASSIFIED DRUG; WATER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FLAVAN 3 OLS; NITRIC OXIDE; VASODILATOR AGENT; FLAVAN-3-OL; FLAVONOID; NITRIC ACID DERIVATIVE; NOS3 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIOLE; ARTERY; ARTERY BLOOD FLOW; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CAPILLARY; CONTROLLED STUDY; CREMASTER MUSCLE; CREMASTERIC ARTERY; DOPPLER FLOWMETRY; ENDOTHELIUM CELL; HEART RATE; HEMATOLOGICAL PARAMETERS; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; MICROCIRCULATION; NONHUMAN; PHOSPHORYLATION; RAT; RED BLOOD CELL VELOCITY; SHEAR STRESS; STOMACH TUBE; SYSTEMIC CIRCULATION; VASODILATATION; VELOCITY; VIDEO MICROSCOPY; ANIMAL CELL; DOSE RESPONSE; DRUG DETERMINATION; DRUG EFFECT; DRUG SCREENING; ERYTHROCYTE COUNT; LASER DOPPLER FLOWMETRY; OXIDATIVE PHOSPHORYLATION; SINGLE DRUG DOSE; ANIMAL; AORTA; BLOOD; BLOOD FLOW VELOCITY; BLOOD PRESSURE; DRUG EFFECTS; METABOLISM; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; SKELETAL MUSCLE; VASCULARIZATION; WESTERN BLOTTING; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; AORTA; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOTTING, WESTERN; FLAVONOIDS; HEART RATE; LASER-DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; MICROSCOPY, VIDEO; MUSCLE, SKELETAL; NITRATES; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; PHOSPHORYLATION; RATS, WISTAR;

EID: 84899682510     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094853.g001     Document Type: Article

References (36)

1. Hammerstone JF, Lazarus SA, Mitchell AE, Rucker R, Schmitz HH. (1999) Identification of procyanidins in cocoa (Theobroma cacao) and chocolate using high-performance liquid chromatography/mass spectrometry. J Agric Food Chem 47:490-496. (Pubitemid 29185214)
2. Hatano T, Miyatake H, Natsume M, Osakabe N, Takizawa T, et al. (2002) Proanthocyanidin glycosides and related polyphenols from cacao liquor and their antioxidant effects. Phytochemistry 59:749-758 (Pubitemid 34269948)
3. Sanbongi C, Osakabe N, Natsume M, Takizawa T, Gomi S, et al. (1998) Antioxidative polyphenols isolated from Theobroma cacao. J Agric Food Chem 46:454-457. (Pubitemid 128488407)
4. Buitrago-Lopez A, Sanderson J, Johnson L, Warnakula S, Wood A, et al. (2011) Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. Available: http://www.bmj.com/content/343/bmj. d4488Accessed5December2013.
5. Larsson SC, Virtamo J, Wolk A. (2012) Chocolate consumption and risk of stroke: a prospective cohort of men and meta-analysis. Neurology 79:1223-1229.
6. Taubert D, Roesen R, Schömig E. (2007) Effect of cocoa and tea intake on blood pressure: a meta-analysis. Arch Intern Med 167:626-634. (Pubitemid 46603652)
7. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, et al. (2008)Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr 88:38-50. (Pubitemid 351988681)
8. Desch S, Schmidt J, Kobler D, Sonnabend M, Eitel I, et al. (2010)Effect of cocoa products on blood pressure: systematic review and meta-analysis. Am J Hypertens 23:97-103
9. Ried K, Sullivan T, Fakler P, Frank OR, Stocks NP. (2010) Does chocolate reduce blood pressure? A meta-analysis. BMC Med. 28;8:39 Available: http:// www.biomedcentral.com/1741-7015/8/39.Accessed5December2013.
10. Tokede OA, Gaziano JM, DjousséL. (2011)Effects of cocoa products/dark chocolate on serum lipids: a meta-analysis. Eur J Clin Nutr 65:879-886
11. Shrime MG, Bauer SR, McDonald AC, Chowdhury NH, Coltart CE, et al. (2011) Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies. J Nutr 141:1982-1988.
12. Hooper L, Kay C, Abdelhamid A, Kroon PA, Cohn JS, et al. (2012) Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr 95:740-751
13. Schroeter H, Heiss C, Balzer J, Kleinbongard P, Keen CL,et al. (2006) (-)- Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A 103:1024-1029. (Pubitemid 43212215)
14. Monahan KD, Feehan RP, Kunselman AR, Preston AG, Miller DL, et al. (1985) Dose-dependent increases in flow-mediated dilation following acute cocoa ingestion in healthy older adults. J Appl Physiol 111:1568-1574
15. Balzer J, Rassaf T, Heiss C, Kleinbongard P, Lauer T, et al. (2008) Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial. J Am Coll Cardiol 51:2141-2149. (Pubitemid 351713684)
16. Birk GK, Dawson EA, Batterham AM, Atkinson G, Cable T, et al. (2013) Effects of exercise intensity on flow mediated dilation in healthy humans. Int J Sports Med 34:409-414
17. Katayama K, Fujita O, Iemitsu M, Kawano H, Iwamoto E, et al. (2013) The effect of acute exercise in hypoxia on flow-mediated vasodilation. Eur J Appl Physiol 113:349-357.
18. Chen H, Zhang L, Zhang M, Song X, Zhang H, et al. (2013) Relationship of depression, stress and endothelial function in stable angina patients. Physiol Behav 118:152-158
19. Osakabe N, Yamagishi M, Sanbongi C, Natsume M, Takizawa T, et al. (1998) The antioxidative substances in cacao liquor. J Nutr Sci Vitaminol 44:313-321 (Pubitemid 28294119)
20. Natsume M, Osakabe N, Yamagishi M, Takizawa T, Nakamura T, et al. (2000) Analyses of polyphenols in cacao liquor, cocoa, and chocolate by normal-phase and reversed-phase HPLC. Biosci Biotechnol Biochem 64:2581-2587.
21. Misko TP, Schilling RJ, Salvemini D, Moore WM, Currie MG. (1993) A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 214:11-16. (Pubitemid 23300346)
22. Wentzel JJ, Chatzizisis YS, Gijsen FJ, Giannoglou GD, Feldman CL, et al. (2012)Endothelial shear stress in the evolution of coronary atherosclerotic plaque and vascular remodelling: current understanding and remaining questions. Cardiovasc Res 96:234-243.
23. Yamamoto K, Ando J. (2011) New molecular mechanisms for cardiovascular disease:blood flow sensing mechanism in vascular endothelial cells. J Pharmacol Sci 116:323-331.
24. Davis ME, Cai H, Drummond GR, Harrison DG. (2001)Shear stress regulates endothelial nitric oxide synthase expression through c-Src by divergent signaling pathways. Circ Res 89:1073-1080 (Pubitemid 34640876)
25. Rakobowchuk M, Harris E, Taylor A, Baliga V, Cubbon RM, et al. (2012) Heavy and moderate interval exercise training alters low-flow-mediated constriction but does not increase circulating progenitor cells in healthy humans. Exp Physiol. 97:375-385.
26. Green DJ, Maiorana A, O'Driscoll G, Taylor R. (2004) Effect of exercise training on endothelium-derived nitric oxide function in humans. J Physiol 561:1-25. (Pubitemid 39549463)
27. Ramirez-Sanchez I, Maya L, Ceballos G, Villarreal F. (2010) (-)-epicatechin activation of endothelial cell endothelial nitric oxide synthase, nitric oxide, and related signaling pathways. Hypertension 55:1398-1405.
28. Ramirez-Sanchez I, Maya L, Ceballos G, Villarreal F. (2011) (-)-Epicatechin induces calcium and translocation independent eNOS activation in arterial endothelial cells. Am J Physiol Cell Physiol 300:C880-C887.
29. Brossette T, Hundsdörfer C, Kröncke KD, Sies H, Stahl W. (2011)Direct evidence that (-)-epicatechin increases nitric oxide levels in human endothelial cells. Eur J Nutr 50:595-599.
30. Baba S, Osakabe N, Natsume M, Muto Y, Takizawa T, et al. (2001) In vivo comparison of the bioavailability of (+)-catechin, (2)-epicatechin and their mixture in orally administered rats. J Nutr 131:2885-2891. (Pubitemid 33063119)
31. Natsume M, Osakabe N, Oyama M, Sasaki M, Baba S, et al. (2003) Structures of (-)-epicatechin glucuronide identified from plasma and urine after oral ingestion of (-)-epicatechin: differences between human and rat. Free Radic Biol Med 34:840-849. (Pubitemid 36316068)
32. Byun EB, Ishikawa T, Suyama A, Kono M, Nakashima S, et al. (2012) A procyanidin trimer, C1, promotes NO production in rat aortic endothelial cells via both hyperpolarization and PI3K/Akt pathways. Eur J Pharmacol 692:52-60.
33. Baba S, Osakabe N, Natsume M, Terao J. (2002)Absorption and urinary excretion of procyanidin B2 [epicatechin-(4beta-8)-epicatechin] in rats. Free Radic Biol Med 33:142-148. (Pubitemid 34681016)
34. Spencer JP, Schroeter H, Rechner AR, Rice-Evans C. (2001)Bioavailability of flavan-3-ols and procyanidins: gastrointestinal tract influences and their relevance to bioactive forms in vivo. Antioxid Redox Signal 3:1023-39. (Pubitemid 34027360)
35. Webb RC, Myers JH. (1979) Skeletal muscle capillary densities during reactive hyperemia. Experientia 35:1476-1477.
36. Honig CR, Odoroff CL, Frierson JL. (1980) Capillary recruitment in exercise: rate, extent, uniformity, and relation to blood flow. Am J Physiol 238:H31-H42. (Pubitemid 10109775)